CD274 and non-small cell lung carcinoma: Our meta-analysis reported that patients with NSCLC treated with PD-1/PD-L1 inhibitors had higher QOL and fewer adverse symptoms than those with standard chemotherapy, indicating that early social, psychological, and spiritual support can improve the quality of life.